Methotrexate based chemotherapy and deferred radiotherapy for primary central nervous system lymphoma (PCNSL): single institution experience

By Silvani A.   Salmaggi A.   Eoli M.   Lamperti E.   Broggi G.   Marras C.   Fariselli L.   Milanesi I.   Fiumani A.   Gaviani P.   Erbetta A.   Giovagnoli A.   Pollo B.   Botturi A.   Boiardi A.  

Journal of Neuro-Oncology, Vol. 82, Iss. 3, 2007-05 ,pp. : 273-279

Springer Publishing Company

Access to resources Recommend Favorite

Methotrexate re-challenge for recurrent primary central nervous system lymphoma

By Pentsova Elena   DeAngelis Lisa   Omuro Antonio  

Journal of Neuro-Oncology, Vol. 117, Iss. 1, 2014-03 ,pp. : 161-165

Springer Publishing Company

Access to resources Recommend Favorite

Primary Central Nervous System Lymphoma: Treatment with Chemotherapy and Radiotherapy

By Sarazin M.   Ameri A.   Monjour A.   Nibio A.   Poisson M.   Delattre J.Y.  

European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. : 2003-2007

Elsevier

Access to resources Recommend Favorite

Primary non-Hodgkin’s lymphoma of the bone: A single institution experience

By Deshmukh C.   Bakshi A.   Parikh P.   Nair R.   Pai V.   Gupta S.   Shaikh A.   Muckaden M.   Naresh K.   Saikia T.  

Medical Oncology, Vol. 21, Iss. 3, 2004-09 ,pp. : 263-267

Humana Press, Inc

Access to resources Recommend Favorite

Immunohistological profiling by B-cell differentiation status of primary central nervous system lymphoma treated by high-dose methotrexate chemotherapy

By Kinoshita Manabu   Hashimoto Naoya   Izumoto Shuichi   Okita Yoshiko   Kagawa Naoki   Maruno Motohiko   Ohnishi Takanori   Arita Norio   Yoshimine Toshiki  

Journal of Neuro-Oncology, Vol. 99, Iss. 1, 2010-08 ,pp. : 95-101

Springer Publishing Company

Access to resources Recommend Favorite